These patients show excessive, leukemia cell-mediated fibrinolysis that could be inhibited by anti-AnxA2 antibodies, in line with a function of AnxA2-S100A10 as cell surface receptor for tPA and plasminogen, triggering plasmin generation and thus fibrin degradation97,125. Here, ANXA2 is linked to leukemia.